CERo Therapeutics Holdings Inc (NASDAQ: CERO) is -98.30% lower on its value in year-to-date trading and has touched a low of $0.06 and a high of $12.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CERO stock was last observed hovering at around $0.21 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.19, the stock is 75.31% and 87.80% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.69 million and changing -11.66% at the moment leaves the stock -85.00% off its SMA200. CERO registered -98.28% loss for a year compared to 6-month loss of -83.43%. The firm has a 50-day simple moving average (SMA 50) of $0.0982 and a 200-day simple moving average (SMA200) of $1.30234.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 102.82% gain in the last 1 month and extending the period to 3 months gives it a 28.31%, and is 165.16% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 35.04% over the week and 15.90% over the month.
CERo Therapeutics Holdings Inc (CERO) has around 9 employees, a market worth around $28.14M and $0.00M in sales. Distance from 52-week low is 194.34% and -98.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-682.23%).
The shares outstanding are 51.35M, and float is at 41.15M with Short Float at 3.89%.
CERo Therapeutics Holdings Inc (CERO) Insider Activity
The most recent transaction is an insider sale by YK Bioventures Opportunities G, the company’s 10% Owner. SEC filings show that YK Bioventures Opportunities G sold 3,250,000 shares of the company’s common stock on Oct 10 ’24 at a price of $0.10 per share for a total of $0.33 million. Following the sale, the insider now owns 22.62 million shares.
